NCT02953418View on ClinicalTrials.gov

RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous Neoplasia

NATerminatedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

July 20, 2019

Study Completion Date

July 20, 2019

Conditions

Esophageal Squamous Cell Neoplasia (ESCN)

Interventions

DEVICE

Radiofrequency ablation

RFA

Trial Locations (1)

100021

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

Sponsors

Lead Sponsor

Medtronic - MITG

All Listed Sponsors

lead

Medtronic - MITG

INDUSTRY